Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Healthcare News by GLG Council Members

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Analysis of: Autism linked with rainfall in study (www.boston.com)
While any association is possible, this looks like so many others--a coexistence, with no demonstrable suggestion of cause-and-effect.
Analysis of: Rapid HIV Testing in the ER Boosts Diagnoses, Screening (www.medcompare.com)
-I'm thrilled to see that a provider evaluating someone for an STD also tests for HIV -but- -I'm appalled that people can be seen in an ER for a suspected STD, just like I would be for those that go for colds and ear infections.  How much did each of those chlamydia and gonorrhea and syphilis diagnoses cost per patient?  And who are we kidding when we pretend that an ER can effectively...
November 10, 2008
Wild speculation
Analysis of: Autism linked with rainfall in study (www.boston.com)
I do not believe that any conclusions can be drawn from these data unless they can be confirmed by a larger, more wide ranging population sampling.
Analysis of: Autism linked with rainfall in study (www.boston.com)
The incidence of autism spectrum disorder (ASD) is now reported at 1 of out every 150 births in N. America. Some 30 years ago the statistic for ASD was 1 in 10,000 births. There are a number of developments in the last 30 years that clearly represent more potential significance in understanding the causes of ASD than geographic variations in rainfall.  During this 30 year period...
Analysis of: Pharma need not worry too much about President Obama (www.pharmatimes.com)
President elect Obama will try , most probably unsuccessfully, to take on insurance companies in orfder to fulfill his election promises of "close to universal" health care. Generics will thrive, but Big Phrama , especially those with innovative products and biotech companies will continue to prosper.
Analysis of: Autism linked with rainfall in study (www.boston.com)
A recent study infers taht periods of increased rainfall could be linked to increase in number of children dioagnosed with autism. The causla l;ink of rainfall is unlikely, but most probably reflects other factors like children staying more indoors and thus watch more TV, get less sun exposure and less VIT D production, and more exposure to cleaning products. New study will help to further confuse...
Analysis of: Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer (www.gene.com)
Genetech's Avastin have shown modest increase in progresion free survival and overall survival in patients with gliobalstoma multiforme, the most common and most agressive malignant brain tumor With such data, Avastin is expected to join Temodar as chemotherapy agent approved for this tumor with high mortality
Louis Sanfilippo, MD, President
Louis Sanfilippo, MD, President
LCS Group, LLC
Analysis of: AstraZeneca Announces European SEROQUEL XR Submission for the Treatment of Generalised Anxiety Disorder (www.pharmalive.com)
Astra Zeneca is pursuing important medical and, of course, commercial goals by seeking the expanded clinical indications of major depression and generalized anxiety disorder for Seroquel XR, heir to blockbuster Seroquel (quetiapine).  This latest EU submission culminates regulatory submissions made for both disorders in the US and EU this year.  While there is the obvious need to supplant...
Analysis of: Healthcare Tech Companies Could Benefit from Obama Plan (money.cnn.com)
President-Elect Obama made reforming the U.S. healthcare system a central plank of his campaign.  A key initiative calls for spending $10 billion a year over the next five years ($50 billion total) to computerize health records and prescribe more treatments digitally. 
Analysis of: Pharma need not worry too much about President Obama (www.pharmatimes.com)
The implication is that our new chief executive has "bigger fish to fry" than attaching drug costs??
Previous Page : 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Next251 to 260 of 5733
Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Become a GLG Client to speak with any expert

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Request more information







*Inquiries subject to client acceptance process


Analytics


Generated at 2009-01-08T19:00:17.880